News

Neuronetics to Expand Influence with Russell Index Inclusion

Neuronetics to Expand Influence with Russell Index Inclusion

Neuronetics Set for Major Milestone in Healthcare Industry

Neuronetics, Inc. (NASDAQ: STIM), a leading medical technology company based in Malvern, Pennsylvania, is excited to announce its impending inclusion in both the Russell 3000 and Russell 2000 indexes. This significant change will officially take effect following the annual reconstitution of the Russell indexes, right after the US market opens on June 30.

The Russell indexes are widely regarded by investment managers and institutional investors, serving as key benchmarks for various active investment strategies and index funds. By the end of June 2024, approximately $10.6 trillion of assets were being tracked against these indexes, showcasing their critical role in the financial marketplace.

Understanding the Russell Indexes

The Russell 3000 Index encompasses the largest 3,000 public companies in the U.S. by market capitalization, while the Russell 2000 Index is specifically dedicated to the small-cap sector. Each year, these indexes undergo a reconstitution process that involves re-evaluating companies based on total market capitalization as of a set date, which was April 30 of this year. Membership in these indexes fosters inclusion in additional growth and value style indexes as well.

Impact of Inclusion on Neuronetics

Keith J. Sullivan, President and CEO of Neuronetics, emphasized the importance of this inclusion, stating that it validates the company's strategic vision and operational success. He noted, "This milestone enhances our visibility among institutional investors and reflects our significant progress in transforming mental healthcare delivery. We continue to expand access to our innovative treatments, positioning ourselves well for growth and delivering value to patients and shareholders alike."

Expanding Innovative Mental Health Solutions

Neuronetics is not just about achieving a milestone; it also aims at changing the landscape of mental health treatment. As a pioneer in neuroscience, the company focuses on providing effective treatment options beyond traditional medication. The NeuroStar Advanced Therapy is a standout and non-invasive treatment designed for patients struggling with conditions when conventional therapies have failed.

Neuronetics operates Greenbrook TMS Inc. treatment centers across the country, offering NeuroStar as a premier therapy for Major Depressive Disorder (MDD). The success is evident with over 7.4 million NeuroStar treatments administered to date, all backed by extensive clinical data, including the largest depression outcomes registry globally.

Comprehensive Treatment Solutions

The NeuroStar Advanced Therapy System has received FDA clearance for adults with MDD and can help patients exhibiting symptoms of anxiety linked to their depression. Additionally, Greenbrook treatment centers offer innovative treatments like SPRAVATO (esketamine), specifically tailored for those battling treatment-resistant depression.

Looking Ahead: Future Prospects for Neuronetics

The positive momentum for Neuronetics is palpable, especially with the path towards achieving cash flow positivity this year. As the company continues to enhance its operational model and expand its reach, it’s poised for robust growth and greater market presence. The upcoming inclusion in the Russell indexes will likely serve as a launchpad for further advancements and opportunities in the healthcare field.

As Neuronetics continues to innovate and expand, stakeholders are optimistic about the changes ahead. This strategic move assures investors of the company's commitment to improving mental health care, benefiting both patients and shareholders.

Frequently Asked Questions

What companies are part of the Russell 3000 and Russell 2000?

The Russell 3000 includes the top 3,000 U.S. public companies by market capitalization, while the 2000 subset comprises smaller capitalization firms.

Why is Neuronetics joining these indexes?

Neuronetics is joining due to its significant growth and market capitalization, validating its operational success and strategic vision in the healthcare industry.

What are the benefits of being part of these indexes?

Inclusion enhances visibility among institutional investors and can lead to increased investments and partnerships, reinforcing company growth.

What treatments does Neuronetics offer?

Neuronetics provides the NeuroStar Advanced Therapy, a non-invasive treatment for MDD, and operates treatment centers that also offer SPRAVATO for treatment-resistant depression.

What is the significance of the NeuroStar therapy?

The NeuroStar therapy is recognized as a leading TMS treatment option backed by a substantial clinical data set, demonstrating its effectiveness for patients who have not responded to traditional treatments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Rehab Equipment Growth Meets a Brutal Access Gap

Updated Category News Views 89

Rehabilitation demand is piling up faster than the equipment can reach people. That is the uncomfortable fact sitting beneath Wissen Research's forecast for a global rehabilitation equipment market rising from $19.1 billion in 2026 to $25.8 billion by 2031, a 6.2% annual growth rate. It is a respectable expansion story, not some rocket-ship fairy tale. More important, it...

Continue Reading
Precision Metal Forming Is Industry's Quiet Backbone

Updated Category News Views 88

A fraction of a millimeter can turn a perfectly good industrial part into an expensive headache. That unglamorous reality sits at the center of Michele Caulfield's discussion of precision metal forming for HelloNation, and it deserves more attention than it usually gets. Investors watching manufacturing tend to chase flashy automation headlines, big aerospace orders, or...

Continue Reading
A Parish Memoir That Sends Its Proceeds Back Home

Updated Category News Views 114

Some books arrive with a thunderclap; this one shows up carrying a folding chair, a prayer book, and a memory that refuses to leave. You Give Them Something to Eat, the new memoir from Fr. Michael J Rieder, is built from more than a hundred short chapters rather than one grand, polished life story. That choice fits the material. Parish life is rarely a clean parade of...

Continue Reading
DocLinq Takes Aim at Care Gaps Between Office Visits

Updated Category News Views 149

Healthcare's most expensive loose ends often pile up after the appointment ends. DocLinq, launched from Columbia, Maryland, is taking a run at that awkward stretch between office visits, where records sit in separate systems, chronic-care follow-up gets uneven, and patients are expected to remember far more than any human reasonably can. This is not a story about AI...

Continue Reading
Parents Hand Kids Devices Years Before They Intended

Updated Category News Views 286

A nine-year-old with a smartphone used to raise eyebrows; this survey says it is increasingly the household baseline. All About Cookies, working with parental-control company Bark, surveyed U.S. parents and found that children typically receive personal devices well before their parents believe they should. That mismatch is not some cute little parenting contradiction. It...

Continue Reading
CloudBackend's €6.6M Test: Can Vibe Code Become SaaS?

Updated Category News Views 108

A prototype is cheap theatre; keeping it alive after customers arrive is where the bill lands. CloudBackend has raised €6.6 million to attack that unglamorous, absolutely vital stretch between an AI-made app and an actual software business. The round is led by Carl-Henric Svanberg's family office, while existing backer M2 Asset Management increased its stake. That is a...

Continue Reading
Snowrise Targets the Blind Spots in CPG Sales Data

Updated Category News Views 128

A sales total can look healthy while the floorboards are quietly rotting underneath it. That is the uncomfortable CPG problem Snowrise is aiming at: brands know what moved last quarter, but often cannot identify which stores, channels, communities, or promotions actually created the result. Plenty of management teams still steer by topline revenue, net distribution gains,...

Continue Reading
Hanmi Compressor Tests Vietnam Before Wider Expansion

Updated Category News Views 125

Compressed air is the sort of factory necessity nobody brags about until it fails, and that is precisely why Hanmi Compressor’s Vietnam plan deserves a sober look. The Daegu-based specialist is not arriving with a grand export victory lap. It is still building the front door: a website, a promotional video, and a process for finding Vietnamese manufacturers and...

Continue Reading
Resolve Adds Cahaba in Birmingham Pain-Care Expansion

Updated Category News Views 36

Pain-care consolidation has a peculiar way of looking tidy in a release and messy in the real world. Resolve Pain Solutions announced on November 18, 2026, that it has acquired Cahaba Pain and Spine Care, an established provider serving greater Birmingham, Alabama. On its face, this is a straightforward expansion move: buy a respected local practice, retain its physician...

Continue Reading
Excel Treatment Center Adds ART Trauma Therapy Option

Updated Category News Views 117

Trauma rarely arrives at an addiction program wearing a name tag. Excel Treatment Center in Dover, New Jersey, is responding to that uncomfortable reality by adding Accelerated Resolution Therapy® (ART) to the individual, group, and family therapy already available to its clients. The center says its therapists have completed ART training, and the approach is now part of...

Continue Reading

Top 5 Most Recently Viewed Articles

Current Trends in Short Interest Impacting PayPal Stock

Updated Category News Views 262

Understanding PayPal Holdings Inc and Its Market Position PayPal Holdings Inc (NYSE: PYPL) remains a prominent player in the digital payments space, continuing to see fluctuations in its market sentiment. Recently, the company has noted a significant increase in short interest as a percentage of float, climbing by 11.57%. This rise has brought the total number of shares...

Continue Reading
WillScot Plans Upcoming Earnings Call and Webcast for Q1

Updated Category News Views 152

WillScot Holdings Corporation to Share Q1 Results WillScot Holdings Corporation, a renowned leader in providing innovative temporary flexible space solutions, has announced its schedule for releasing the financial results for the first quarter of 2025. This eagerly anticipated announcement is set to take place on May 1, 2025, after market close, allowing investors and...

Continue Reading
Denarius' Bold Move: Debentures Target Early Exit

Updated Category News Views 53

Treading Against Debentures: Denarius' Maneuver Denarius Metals Corp. doesn't seem keen on playing it safe with convertible debentures tying up its business. Jaw-dropping numbers in news like this make you stop and wonder: Is this strategy brilliance, or just a roll of the dice? Time-Pressured Decisions Denarius Metals, trading as OTCQX: DNRSF, has kicked off a whirlwind...

Continue Reading
Katten Partners Recognized Among Top Experts in Crypto Sector

Updated Category News Views 185

Katten Partners Shine in Crypto Industry Recognition Katten, a well-respected law firm, has gained significant attention for its leadership in the evolving digital asset landscape. Three of its distinguished partners have been recognized by Citywealth, a leading publication in the private wealth sector, for their exceptional contributions to the cryptocurrency domain. The...

Continue Reading
Anticipating Logitech International's Earnings Success

Updated Category News Views 160

Anticipating Logitech International's Earnings Success Logitech International (NASDAQ: LOGI) is gearing up for its next quarterly earnings announcement, and investors are keenly observing potential developments. As the company prepares to report earnings, expectations are high for positive news regarding financial forecasts and results. Analyst Predictions for Earnings...

Continue Reading